These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21284268)

  • 21. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
    Fernando HC; Sasatomi E; Christie NA; Buenaventura PO; Finkelstein SD; Yousem SA; Soose R; Close JM; Luketich JD
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):87-91. PubMed ID: 14752417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Assessment of surgery for stage IV non-small cell lung cancer].
    Yamada T; Tanahashi M; Moriyama T; Hikosaka Y; Yoshitomi H
    Kyobu Geka; 2006 Jan; 59(1):4-10. PubMed ID: 16440677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
    Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival.
    Veeramachaneni NK; Battafarano RJ; Meyers BF; Zoole JB; Patterson GA
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):466-9. PubMed ID: 18249130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predicting poor survival after resection of stage IA non-small cell lung cancer.
    Paleari L; Russo P; Cesario A; Granone P
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):241-2. PubMed ID: 18603108
    [No Abstract]   [Full Text] [Related]  

  • 28. Survival and Racial Differences of Non-Small Cell Lung Cancer in the United States Military.
    Brzezniak C; Satram-Hoang S; Goertz HP; Reyes C; Gunuganti A; Gallagher C; Carter CA
    J Gen Intern Med; 2015 Oct; 30(10):1406-12. PubMed ID: 25805503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethnic disparities in conditional survival of patients with non-small cell lung cancer.
    Wang SJ; Fuller CD; Thomas CR
    J Thorac Oncol; 2007 Mar; 2(3):180-90. PubMed ID: 17410040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The changing face of lung cancer.
    Barnes DJ
    Chest; 2004 Dec; 126(6):1718-21. PubMed ID: 15596660
    [No Abstract]   [Full Text] [Related]  

  • 31. Highlights: Are race and ethnicity playing a useful structural role in epidemiologic research?
    Am J Hypertens; 2011 Feb; 24(2):121. PubMed ID: 21248729
    [No Abstract]   [Full Text] [Related]  

  • 32. Equity in Lung Cancer Care and Outcomes.
    Ibrahim SA
    J Gen Intern Med; 2015 Oct; 30(10):1385-6. PubMed ID: 25903994
    [No Abstract]   [Full Text] [Related]  

  • 33. Improved survival in hairy cell leukaemia over three decades: a SEER database analysis of prognostic factors.
    Chandran R; Gardiner SK; Smith SD; Spurgeon SE
    Br J Haematol; 2013 Nov; 163(3):407-9. PubMed ID: 23889044
    [No Abstract]   [Full Text] [Related]  

  • 34. Socioeconomic Factors Associated with Lack of Treatment in Early Stage Non-Small Cell Lung Cancer.
    Dalwadi SM; Zhang J; Bernicker EH; Butler EB; Teh BS; Farach AM
    Cancer Invest; 2019; 37(9):506-511. PubMed ID: 31530035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Race and ethnicity in the intensive care unit: what do we know and where are we going?
    Muni S; Curtis JR
    Crit Care Med; 2011 Mar; 39(3):579-80. PubMed ID: 21330852
    [No Abstract]   [Full Text] [Related]  

  • 36. From the Centers for Disease Control and Prevention. Recent trends in mortality rates for four major cancers, by sex and race/ethnicity--United States, 1990-1998.
    JAMA; 2002 Mar; 287(11):1391-2. PubMed ID: 11911130
    [No Abstract]   [Full Text] [Related]  

  • 37. Ethnicity has overtaken race in medical science: MEDLINE-based comparison of trends in the USA and the rest of the world, 1965-2005.
    Afshari R; Bhopal RS
    Int J Epidemiol; 2010 Dec; 39(6):1682-3. PubMed ID: 20089694
    [No Abstract]   [Full Text] [Related]  

  • 38. Survival rates and race--clues to curing childhood cancer.
    Mertens AC
    Pediatr Blood Cancer; 2011 Mar; 56(3):333-4. PubMed ID: 21225907
    [No Abstract]   [Full Text] [Related]  

  • 39. [Lung cancer metastasizing to the prostate: case report and literature review].
    Barba Abad J; Robles García JE; Tolosa Eizaguirre E; Panizo Santos A; Zudaire Bergera JJ
    Actas Urol Esp; 2010 Nov; 34(10):918-20. PubMed ID: 21159299
    [No Abstract]   [Full Text] [Related]  

  • 40. Aspirin use and racial differences in Non-Small cell lung cancer survival: What is the plot?
    Mormile R
    Pulm Pharmacol Ther; 2018 Dec; 53():79. PubMed ID: 30316978
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.